| Dr Mohammad Feroz Padela, MD | |
|
718 Teaneck Rd, Teaneck, NJ 07666-4245 | |
| (201) 869-6868 | |
| (201) 379-5708 |
| Full Name | Dr Mohammad Feroz Padela |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 41 Years |
| Location | 718 Teaneck Rd, Teaneck, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700855772 | NPI | - | NPPES |
| 7004508 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MA056887 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Name Medical Center | Teaneck, NJ | Hospital |
| Mercy St Vincent Medical Center | Toledo, OH | Hospital |
| Miami Valley Hospital | Dayton, OH | Hospital |
| Good Samaritan Hospital | Cincinnati, OH | Hospital |
| The Jewish Hospital-mercy Health | Cincinnati, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excelcare Medical Associates Pa | 4284647868 | 182 |
| Evokes, Llc | 4880983832 | 12 |
| Titan Neurophysiology Pa | 7113160433 | 8 |
| American Intraoperative Monitoring Llc | 8527230333 | 5 |
| Tiger Neurophysiology, P.c. | 8628214822 | 5 |
| Longhorn Neurophysiology Pa | 9032373154 | 10 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | Excelcare Medical Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992736300 PECOS PAC ID: 4284647868 Enrollment ID: O20060727000044 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | Tiger Neurophysiology, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265778237 PECOS PAC ID: 8628214822 Enrollment ID: O20130412000470 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | Titan Neurophysiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649614777 PECOS PAC ID: 7113160433 Enrollment ID: O20141231000915 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | Evokes, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508231267 PECOS PAC ID: 4880983832 Enrollment ID: O20170516001572 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | American Intraoperative Monitoring Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972551893 PECOS PAC ID: 8527230333 Enrollment ID: O20170714000700 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | Wildcat Neurophysiology Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073026993 PECOS PAC ID: 4789943804 Enrollment ID: O20180118001500 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Entity Name | Longhorn Neurophysiology Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811256928 PECOS PAC ID: 9032373154 Enrollment ID: O20230525002570 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mohammad Feroz Padela, MD 86 Davinci Dr, Monmouth Junction, NJ 08852-3502 Ph: (973) 471-3730 | Dr Mohammad Feroz Padela, MD 718 Teaneck Rd, Teaneck, NJ 07666-4245 Ph: (201) 869-6868 |
News Archive
MicroStockProfit.com announces an investment report featuring Cell Therapeutics Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.
At the time of diagnosis, the majority of breast cancers are categorized as estrogen-receptor positive, or hormone sensitive, which means their cancerous cells may need estrogen to grow. Patients with this type of cancer often respond favorably to treatments called aromatase inhibitors, like tamoxifen, which cause cell death by preventing estrogen from reaching the cancerous cells.
Honeycomb-like arrays of tiny, lab-grown cancers could one day help doctors zero in on individualized treatments for ovarian cancer, an unpredictable disease that kills more than 14,000 women each year in the United States alone.
Cancer researcher Professor Jennifer Byrne from the University of Sydney is hoping to change this with the creation of a world-first fact-checking program that is tackling the problem of incorrectly published biomedical research results, whether intentional or otherwise.
Thousands of members of the National Association of Letter Carriers (NALC), an organization affiliated with the AFL-CIO, will head for scores of local bowling centers across the nation on Sunday, Nov. 6.
› Verified 1 days ago
Jeremy Steinberger, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 590 Winthrop Rd, Teaneck, NJ 07666 Phone: 212-241-5055 |